5160722025-04-012025-06-305160722025-06-305160722025-04-012025-06-30in-capmkt:OtherExpenses1Member5160722025-04-012025-06-30in-capmkt:OtherExpenses2Member5160722025-04-012025-06-30in-capmkt:OtherExpenses3Member5160722025-04-012025-06-30in-capmkt:OtherExpenses4Member5160722025-04-012025-06-30in-capmkt:OtherExpenses5Member5160722025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares516072VISHNUNOTLISTEDINE270I01022VISHNU CHEMICALS LIMITEDMain BoardEquity2025-04-012026-03-312025-08-022025-07-28INRLakhsQuarterlyFirst quarterSingle segmentOperating Segment2025-08-0214:30:002025-08-0215:20:00Not applicablefalsetrue2025-04-012025-06-30UnauditedStandalone262514900054822000267997100015032100000-33968000013335800061542000589310001016459000243382000024615100002461510005913700070510006618800001799630000000179963000-37400017958900013463100022.672.67002.672.671 The above unaudited Standalone Financial Results of Vishnu Chemicals Limited as reviewed by the audit committee has been approved by the Board of Directors at its meeting held on August 02 2025 The Statutory Auditors of the company have carried out a limited review on the standalone financial results for the quarter ended June 30 2025 and expressed an unmodified opinion thereon <BR> <BR> 2 The standalone financial results of the Company have been prepared in accordance with the Indian Accounting Standards IND AS prescribed under Section 133 of the Companies Act 2013 the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and guidelines issued by the Securities and Exchange Board of India SEBI <BR> <BR> 3 The figures for the quarter ended March 31 2025 are the balancing figures between the audited figures in respect of the full financial year ended March 31 2025 and published year to date figures up to third quarter of the financial year ended March 31 2025 <BR> <BR> 4 Previous years figures have been regrouped reclassified rearranged wherever necessary to correspond with those of the current year <BR> <BR> 5 The Company is engaged in the manufacture and sale of Specialty Chemicals which constitutes a single reportable business segment as per Ind AS 108 Operating Segments However the company has two geographical revenue areas ie 1 Domestic 2 Overseas The breakup of Income is as under <BR> <BR> Rs in lakhs <BR> Particulars Quarter Ended Year Ended <BR> Sl 30 Jun 2025 31 Mar 2025 30 Jun 2024 31 Mar 2025 <BR> No Unaudited Unaudited Unaudited Audited <BR> 1 Domestic 14021 17981 13587 60188 <BR> 2 Overseas 12126 11035 12157 48846 <BR> Total Sales 26148 29017 25744 109035Cost of Consumables371406000Power Cost162693000Manufacturing Expenses179170000Selling and Administrative Expenses296559000Other Expenses6631000Remeasurement gains/(losses) on defined benefit Plans-500000-500000-1260000-3740004618000000001179400000